Fernández-de-las-Peñas, C.; Franco-Moreno, A.; Ruiz-Ruigómez, M.; Arrieta-Ortubay, E.; Ryan-Murua, P.; Lumbreras-Bermejo, C.; del-Valle-Loarte, P.; Pellicer-Valero, O.J.; Giordano, R.; Arendt-Nielsen, L.;
et al. Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms? Viruses 2024, 16, 947.
https://doi.org/10.3390/v16060947
AMA Style
Fernández-de-las-Peñas C, Franco-Moreno A, Ruiz-Ruigómez M, Arrieta-Ortubay E, Ryan-Murua P, Lumbreras-Bermejo C, del-Valle-Loarte P, Pellicer-Valero OJ, Giordano R, Arendt-Nielsen L,
et al. Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms? Viruses. 2024; 16(6):947.
https://doi.org/10.3390/v16060947
Chicago/Turabian Style
Fernández-de-las-Peñas, César, Anabel Franco-Moreno, MarÃa Ruiz-Ruigómez, Estibaliz Arrieta-Ortubay, Pablo Ryan-Murua, Carlos Lumbreras-Bermejo, Pablo del-Valle-Loarte, Oscar J. Pellicer-Valero, Rocco Giordano, Lars Arendt-Nielsen,
and et al. 2024. "Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?" Viruses 16, no. 6: 947.
https://doi.org/10.3390/v16060947
APA Style
Fernández-de-las-Peñas, C., Franco-Moreno, A., Ruiz-Ruigómez, M., Arrieta-Ortubay, E., Ryan-Murua, P., Lumbreras-Bermejo, C., del-Valle-Loarte, P., Pellicer-Valero, O. J., Giordano, R., Arendt-Nielsen, L., MartÃn-Garrido, I., & Torres-Macho, J.
(2024). Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms? Viruses, 16(6), 947.
https://doi.org/10.3390/v16060947
